Cargando…
A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products
BACKGROUND: Pharmacological management of chronic neuropathic pain (CNP) still represents a major clinical challenge. Collective harnessing of both the scientific evidence base and clinical experience (of clinicians and patients) can play a key role in informing treatment pathways and contribute to...
Autores principales: | Nutt, David J., Phillips, Lawrence D., Barnes, Michael P., Brander, Brigitta, Curran, Helen Valerie, Fayaz, Alan, Finn, David P., Horsted, Tina, Moltke, Julie, Sakal, Chloe, Sharon, Haggai, O'Sullivan, Saoirse E., Williams, Tim, Zorn, Gregor, Schlag, Anne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418467/ https://www.ncbi.nlm.nih.gov/pubmed/33998895 http://dx.doi.org/10.1089/can.2020.0129 |
Ejemplares similares
-
Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21
por: Schlag, Anne Katrin, et al.
Publicado: (2022) -
Cannabis based medicines and cannabis dependence: A critical review of issues and evidence
por: Schlag, Anne K, et al.
Publicado: (2021) -
Medical cannabis in the UK: From principle to practice
por: Schlag, Anne Katrin, et al.
Publicado: (2020) -
Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017) -
Pharmacotherapy for Neuropathic Pain: A Review
por: Fornasari, Diego
Publicado: (2017)